Choosing fiber sources that are less likely to cause gas or bloating may improve comfort over time
39 Although GLP-1RAs continue to be promising therapies for T2D, their long-term efficacy for weight loss after halting treatment should be further improved
Currently, the FDA has officially approved a higher-dose formulation of semaglutide called Wegovy specifically for chronic weight management in adults who are overweight or obese, even if they do not have diabetes
For most patients, the question isnt which format is most pharmacologically efficient. Its which format will I actually take, every week, for months? A patient who refuses to inject themselves and skips the injection altogether gets zero benefit from semaglutides higher bioavailability
Studies indicate that 25% to 39% of weight lost during GLP-1 treatment can be muscle tissue , highlighting the critical need for strategic exercise planning
About insurance and cost: "Which GLP-1 is most likely to be covered under my insurance plan?" "Will your office handle the prior authorization, and how long does that typically take?" "If the first option is denied, what is the appeal process?" "Are there manufacturer savings programs or coupons available?" "Would a compounded version be an option if brand-name is too expensive?" Cost conversations are not awkward
